Regions
MAIN/REGIONS
regions/
Regions
  1. Americas
  2. Asia & Oceania
  3. Europe
  4. Middle East & Africa
  1. Solutions
  2. Products
  3. Insights
  4. About
  5. Careers
  6. Contact Us
MAIN/search
MAIN/Solutions
Solutions/
SOLUTIONS
  • Research & Development
  • Real World Evidence
  • Commercialization
  • Safety & Regulatory Compliance
  • Technologies
LIFE SCIENCE SEGMENTS
HEALTHCARE SEGMENTS
THERAPEUTIC AREAS

Impacting People's Lives

"We strive to help improve outcomes and create a healthier, more sustainable world for people everywhere.

LEARN MORE
Harness the power to transform clinical development

Reimagine clinical development by intelligently connecting data, technology, and analytics to optimize your trials. The result? Faster decision making and reduced risk so you can deliver life-changing therapies faster.

Research & Development Overview
Research & Development Quick Links
Real World Evidence. Real Confidence. Real Results.

Generate and disseminate evidence that answers crucial clinical, regulatory and commercial questions, enabling you to drive smarter decisions and meet your stakeholder needs with confidence.

REAL WORLD EVIDENCE OVERVIEW
Real World Evidence Quick Links
See markets more clearly. Opportunities more often.

Elevate commercial models with precision and speed using AI-driven analytics and technology that illuminate hidden insights in data.

COMMERCIALIZATION OVERVIEW
Commercialization Quick Links
Service driven. Tech-enabled. Integrated compliance.

Orchestrate your success across the complete compliance lifecycle with best-in-class services and solutions for safety, regulatory, quality and medical information.

COMPLIANCE OVERVIEW
Safety & Regulatory Compliance Quick Links
Intelligence that transforms life sciences end-to-end.

When your destination is a healthier world, making intelligent connections between data, technology, and services is your roadmap.

TECHNOLOGIES OVERVIEW
Technology Quick Links
MAIN/Products
Products/
CLINICAL PRODUCTS
COMMERCIAL PRODUCTS
COMPLIANCE, SAFETY, REG PRODUCTS
REAL WORLD PRODUCTS

CASE STUDY

"Data in a Day

LEARN MORE
MAIN/Insights
Insights/
BLOGS, WHITE PAPERS & CASE STUDIES

Explore our library of insights, thought leadership, and the latest topics & trends in healthcare.

DISCOVER INSIGHTS
THE IQVIA INSTITUTE

An in-depth exploration of the global healthcare ecosystem with timely research, insightful analysis, and scientific expertise.

SEE LATEST REPORTS

INSTITUTE REPORT

"Digital Health Trends 2024 - Implications for Research and Patient Care

READ MORE

EMEA Insights

"IQVIA thought leadership with a focus on EMEA.

Learn more

WHITE PAPER

"DCTs Deliver Big ROI

LEARN MORE

WHITE PAPER

"Capturing value at scale: The $4 billion RWE imperative

LEARN MORE
MAIN/About
About/
FEATURED INNOVATIONS
  • IQVIA Connected Intelligence™
  • IQVIA Healthcare-grade AI™
  • IQVIA AI Assistant
  • Human Data Science Cloud
  • IQVIA Innovation Hub
  • Decentralized Trials
  • Patient Experience Solutions with Apple devices
WHO WE ARE
NEWS & RESOURCES

INVESTOR RELATIONS

"Visit our investor relations site for more information.

LEARN MORE
Unlock your potential to drive healthcare forward

By making intelligent connections between your needs, our capabilities, and the healthcare ecosystem, we can help you be more agile, accelerate results, and improve patient outcomes.

LEARN MORE
IQVIA AI is Healthcare-grade AI

Building on a rich history of developing AI for healthcare, IQVIA AI connects the right data, technology, and expertise to address the unique needs of healthcare. It's what we call Healthcare-grade AI.

LEARN MORE
Meet the IQVIA AI Assistant

Your new expert analyst is here. Be at the forefront of data-driven decision-making with a new generative AI tool that enables you to interact with our products and solutions like never before. Get results you can trust, faster.

LEARN MORE
Your healthcare data deserves more than just a cloud.

The IQVIA Human Data Science Cloud is our unique capability designed to enable healthcare-grade analytics, tools, and data management solutions to deliver fit-for-purpose global data at scale.

LEARN MORE
Innovations make an impact when bold ideas meet powerful partnerships

The IQVIA Innovation Hub connects start-ups with the extensive IQVIA network of assets, resources, clients, and partners. Together, we can help lead the future of healthcare with the extensive IQVIA network of assets, resources, clients, and partners.

LEARN MORE
Proven, faster DCT solutions

IQVIA Decentralized Trials deliver purpose-built clinical services and technologies that engage the right patients wherever they are. Our hybrid and fully virtual solutions have been used more than any others.

LEARN MORE
IQVIA Patient Experience Solutions with Apple devices

Empowering patients to personalize their healthcare and connecting them to caregivers has the potential to change the care delivery paradigm.

LEARN MORE
MAIN/Careers
Careers/
IQVIA Careers
Featured Careers
Stay Connected

WE'RE HIRING

"At IQVIA your potential has no limits. We thrive on bold ideas and fearless innovation. Join us in reimagining what’s possible.

VIEW ROLES
MAIN/Contact Us
Contact Us/

Press Release

IQVIA Consumer Health Choice Awards

Nov 07, 2018

For the second time IQVIA announced the Consumer Health Choice Awards at their yearly client conference, recognizing the best performing brands (umbrella brand) and companies (corporation) of the Russian OTC market 2018. The driving factors for the awards are sales, with a special focus on growth. IQVIA awarded seven winners and to measure true consumer choice, all awards are based on IQVIA PharmaTrend, the sell-out reporting at final retail price value, generally MAT 07/2018. The driving teams behind those companies and brands delivered some outstanding work and can be proud of their achievements! 

#1 OTC brand (value): Nurofen®

In the three previous years we saw each year a different brand on the top spot in Russia: Essentiale, Kagocel and then Nurofen. Now Nurofen is the first brand in years that could defend the first place in the highly dynamic Russian OTC market. Congratulations to the Reckitt-Benckiser team! Runners-up were Detralex, which rose from 6th to 2nd place and pushed Kagocel to 3rd. It will be exciting to see the battle between Nurofen and Detralex next year. 

 

#1 OTC brand (3-year absolute value growth): Detralex®

Absolute growth is a powerful measure as it shows the additional value brought to the market for both trade & consumers. For long-term growth we measured the total contribution over three years – the difference in sales between MAT 07/2015 and MAT 07/2018 and see following brands in ascending order: Rinostop, Mycoderil, Venarus, Miramistin and the winner Detralex from Servier. All five mentioned brands delivered excellent sustainable performance.  Congratulations!

 

#1 OTC brand (annual value growth): Venarus®

We award a second absolute growth price, focusing on current year growth only, to the strongest performer in the last 12 months. Here we saw following five brands shortlisted, again in ascending order: Dolgit, Phosphogliv, Pentalgin, then on second place again Detralex, but on first place, the brand which won the most additional sales in MAT 07/2018 was Venarus from Obolensk. Congratulations to all five brands!

 

#1 OTC brand (annual growth rate of top-100 OTC brands): Dolgit®

Finally, on brand growth we rewarded also relative growth, and this is tricky as it requires to define a cut-off point to not award a brand going from insignificant sales to a high multiple. We decided the cut off at top-100 OTC brands, which represent almost half of the total Russian OTC market. Fast growing brands in this wider cluster can be stars of the future. These brands were fastest growing, in ascending order: Phleboida, Trimedat Valenta, Phosphogliv, and Venarus came second, but the winner was Dolgit from Dr. Theiss. Congratulations! 

 

#1 OTC company (value): OTCPharm

The first of two company awards goes to the #1 OTC company by sales. Three years ago (MAT 07/2015) the biggest OTC company in Russia was Sanofi, however this changed a year later and for the last two years, as well as the current year (a total of three years), the #1 OTC company is OTCPharm. On second place remains Bayer and on third Sanofi, as in last year. OTCPharm would have also won highest absolute growth for 3Y & 1Y periods. OTCPharm is now the most dominating player in the Russian OTC market, it has clearly further strengthened its position over last year. Congratulations!

 

#1 OTC company (3Y CAGR of top-20 companies): Akrikhin-Pharma

As with brands we also have a relative growth winner and we decided the cut-off point to be at the top-20 companies as these are, similarly, representing just over half of the Russian OTC market. As long-term sustainability is important, we took the combined annual growth rate (CAGR) over three years, so the average yearly growth from MAT 07/2015 to MAT 07/2018. The fastest growing companies among the top-20 in ascending order are: Pharmstandard, Bionorica, Valenta, OTCPharm, and only one is growing faster and that is Akrikhin. Congratulations to that achievement to the whole team at Akrikhin! 

 

#1 OTC launch in Russia 2017 (sales in first six months of launch): MestaMidin-Sens

Finally, we would like to award the most successful launch of 2017. To measure this, we have taken all launches (only completely new brands, no line extensions) at any month of 2017 and calculated the sales from the first month of launch down to the sixth month. Here we saw following brands in ascending order: Phazostabil, Exostat and the winner was MestaMidin-Sens from Solopharm, which was launched in August 2017. Congratulations to this achievement – new launches are the lifeblood of the OTC market and it is critical to get them successful – IQVIA can support new launches with extensive services. 

Again, we congratulate the winners of all seven awards for their amazing achievements and look forward to the awards of 2019 – all the best to you all to get into the rankings next year! We at IQVIA are happy to help with all your needs to drive success!

Contact Us